DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and exploitation of bacterial biodiversity to address the urgent, global challenge of antibiotic resistance, reminds its shareholders that they are convened to an Extraordinary General Meeting on October 17, 2022 at 2 p.m. CEST, in the premises of Fieldfisher, 48 rue Cambon, 75001 Paris.
Read the original post:
DEINOVE - Extraordinary General Meeting of October 17, 2022: Appointment of an ad hoc representative
Recommendation and review posted by Fredricko
